Medications for Acute Cough in the Emergency Department

First-Line Treatment Options

Simple home remedies like honey and lemon may be as effective as pharmacological treatments and should be considered first for benign viral cough 1, 2
Central modulation through voluntary cough suppression may be sufficient to reduce cough frequency in some patients 2
Dextromethorphan is the recommended first-line antitussive agent due to its superior safety profile compared to opioid alternatives, with dosing of 60 mg providing optimal cough suppression 1, 3, 4
Standard over-the-counter dosing of dextromethorphan is often subtherapeutic 3
Maximum cough reflex suppression with dextromethorphan occurs at 60 mg and can be prolonged 3
Caution with higher doses of dextromethorphan as some combined preparations contain other ingredients like paracetamol 3
Menthol suppresses cough reflex when administered by inhalation and provides acute but short-lived cough suppression 3
Sedative antihistamines can suppress cough but cause drowsiness, and may be particularly suitable for nocturnal cough 3, 2

Second-Line Options

Codeine is not recommended due to adverse side effect profile 3, 4
Codeine has no greater efficacy than dextromethorphan 3

Special Considerations

For severe paroxysms of postinfectious cough, consider prednisone 30-40 mg daily for a short period 5
Inhaled ipratropium may be tried before central antitussives for postinfectious cough 5
Central acting antitussives like dextromethorphan should be considered only when other measures fail for postinfectious cough 5
If pertussis is suspected, macrolide antibiotics are indicated 5
Isolation for 5 days from the start of treatment is recommended for pertussis 5

Practical Approach to Cough in ED

For benign viral cough, start with non-pharmacological approaches like honey and lemon 1, 2
For additional relief, use dextromethorphan at appropriate doses of 30-60 mg 3
For nocturnal cough, consider first-generation antihistamines 3
For short-term relief of severe symptoms, menthol inhalation can provide quick but brief relief 3
For postinfectious cough, consider inhaled ipratropium first 5
For severe paroxysms of postinfectious cough, short-course prednisone may be beneficial 5

Role of Dextromethorphan in Cough Management

Mechanism and Efficacy

Dextromethorphan is a non-sedating opiate that acts centrally to suppress the cough reflex 6
DM has been shown to reduce cough frequency in some studies, but results are inconsistent across different patient populations 7
At standard doses (30mg), DM may provide modest reduction in cough counts and cough effort (19-36%) in adults with upper respiratory infections 7
There is a dose-response relationship, with maximum cough reflex suppression occurring at 60mg, which is higher than typically recommended in over-the-counter preparations 6

Clinical Applications

For patients with acute bronchitis, antitussive agents like DM can be offered for short-term symptomatic relief (Grade of recommendation C) 8

Limitations and Considerations

Evidence for DM efficacy is mixed, with some studies showing no significant difference compared to placebo in cough frequency or severity 7
DM should not be used for productive cough where clearance of secretions is beneficial 6
Central acting antitussives like DM should be considered only when other measures fail for postinfectious cough 9
DM is not recommended for routine use in acute bronchitis due to inconsistent results 10

Comparison with Other Antitussives

DM has a better safety profile than codeine or pholcodine, with fewer adverse effects 6
Benzonatate offers an alternative to DM with a different adverse effect profile and may be preferred when opioids are contraindicated 11

Recommendations for Clinical Practice

For acute viral cough, simple measures like honey and lemon may be as effective as pharmacological treatments 6
When pharmacological treatment is needed, DM at appropriate doses (30-60mg) can be considered for short-term use 6
Always assess cough characteristics and duration before considering DM therapy, and rule out serious underlying causes requiring specific treatment 11
In patients with postinfectious cough, consider other treatments first (such as inhaled ipratropium) before using central acting antitussives like DM 9

Management of Non-Productive Cough

First-Line Treatment Options

Simple home remedies like honey and lemon may be as effective as pharmacological treatments and should be considered first for benign viral cough 12
Standard over-the-counter dosing of dextromethorphan is often subtherapeutic; maximum cough reflex suppression occurs at 60 mg and can be prolonged 12
Menthol by inhalation provides acute but short-lived cough suppression and can be prescribed as menthol crystals or proprietary capsules 12
First-generation sedative antihistamines can suppress cough but cause drowsiness, making them particularly suitable for nocturnal cough 12

Second-Line Options and Considerations

Codeine and pholcodine have no greater efficacy than dextromethorphan but have a much greater adverse side effect profile (drowsiness, nausea, constipation, physical dependence) and are not recommended 12

Special Considerations

Caution with higher doses of dextromethorphan as some combined preparations contain other ingredients like pain relievers 12
Central modulation through voluntary cough suppression may be sufficient to reduce cough frequency in some patients 12

Practical Algorithm for Non-Productive Cough Management

Honey and lemon mixtures may be used as a non-pharmacological approach 12
Voluntary cough suppression techniques may be used as a non-pharmacological approach 12
Dextromethorphan at appropriate doses (30-60 mg) may be used for additional relief 12
First-generation antihistamines with sedative properties may be used for nighttime cough disrupting sleep 12
Menthol inhalation may be used for quick but temporary relief 12
Codeine-containing products should be avoided due to poor benefit-to-risk ratio 12

Common Pitfalls to Avoid

Using subtherapeutic doses of dextromethorphan that may not provide adequate relief 12
Prescribing codeine-based antitussives which have no efficacy advantage but increased side effects 12

Cough Suppression with Dextromethorphan

Therapeutic Dosing and Safety Considerations

For severe paroxysms, a short-course of prednisone 30-40 mg daily may be indicated, according to the American College of Chest Physicians, in patients with postinfectious cough who have failed initial treatment with inhaled ipratropium and dextromethorphan 13
Cough lasting more than 3 weeks requires a full diagnostic workup rather than continued antitussive therapy, as recommended by the American College of Chest Physicians, to evaluate for alternative diagnoses 13

Clinical Application Algorithm

For postinfectious cough, the American College of Chest Physicians suggests trying inhaled ipratropium before central antitussives, and considering dextromethorphan as a central acting antitussive if ipratropium fails 13

Dextromethorphan Dosing for Cough Treatment

Standard Dosing Regimen

The American College of Chest Physicians recommends dextromethorphan dosing at 10-15 mg three to four times daily, with a maximum daily dose of 120 mg, for effective cough suppression in patients with lung cancer-associated cough 14, 15, 16

Clinical Application Algorithm

First-Line Approach

The CHEST expert panel suggests starting with dextromethorphan 10-15 mg three to four times daily if pharmacological treatment is needed for cough suppression 14, 15, 16

Dose Escalation Strategy

For severe cough requiring maximum suppression, a single 60 mg dose of dextromethorphan can be used, though caution is needed with combination preparations containing acetaminophen or other ingredients 14, 15, 16

Important Safety Considerations and Pitfalls

Common Prescribing Errors

The CHEST expert panel advises checking combination products carefully to avoid excessive amounts of other ingredients like acetaminophen when prescribing dextromethorphan 14, 15, 16

Duration of Treatment

Dextromethorphan should be used for short-term symptomatic relief only, according to the American College of Chest Physicians, and discontinued if cough persists beyond 3 weeks 17

Treatment Failure Management

The CHEST expert panel recommends discontinuing dextromethorphan and trying alternative approaches if no improvement is seen after a short course 16
For opioid-resistant cough, peripherally-acting antitussives like levodropropizine or moguisteine may be considered, as suggested by the CHEST expert panel 14, 15, 16
For refractory cases, nebulized lidocaine may be considered as a last resort, according to the CHEST expert panel 14, 15, 16

Cough Management in Adults

Introduction to Cough Suppression

The American College of Physicians suggests that promethazine has no established efficacy for cough suppression and is primarily used for nausea, allergic conditions, and sedation 18
The British Thoracic Society recommends against using promethazine for cough management, as it is not recommended for this indication 19, 20, 21

Recommended Alternative: Dextromethorphan Alone

The National Comprehensive Cancer Network recommends dextromethorphan 30-60 mg for adult cough suppression, with a maximum daily dose of 120 mg 18
The British Thoracic Society suggests that codeine-based antitussives have no greater efficacy than dextromethorphan but significantly more adverse effects, including drowsiness, nausea, constipation, and physical dependence 19, 20

Mechanism of Honey for Cough Suppression

Proposed Mechanisms

The primary mechanism of honey for cough suppression appears to be central modulation of the cough reflex, where simple voluntary suppression may be sufficient to reduce cough frequency 22
This central modulation is common to various simple remedies including honey, and may explain why simple drinks and linctuses provide symptomatic relief 22
The mechanism is likely non-pharmacological, as patients report benefit from various over-the-counter preparations despite little evidence of specific pharmacological effects 22
Honey acts as a demulcent agent that coats and soothes the irritated upper respiratory tract 22
The viscous nature of honey may provide a protective coating over pharyngeal mucosa, reducing mechanical irritation that triggers the cough reflex 22

Practical Advantages

The non-pharmacological mechanism of honey means it avoids the adverse effects associated with opioid antitussives, such as sedation, respiratory depression, constipation, and dependence 22
The central modulation mechanism explains why honey can be as effective as pharmacological agents without specific receptor binding 22

Limitations of Current Understanding

The exact neurophysiological pathway by which honey modulates the cough reflex centrally remains incompletely understood 22
Whether the effect is purely mechanical, such as demulcent, versus involving taste receptors or other sensory pathways is unclear 22

Dextromethorphan Dosing for Patients with Chronic Kidney Disease

Special Considerations for CKD Patients

No specific dose adjustment of dextromethorphan is required for patients with Chronic Kidney Disease, unlike many other medications metabolized renally, as stated by the American Society of Nephrology 23, 24

Pharmacokinetics and Metabolism

Dextromethorphan is primarily metabolized by CYP2D6 hepatically, not renally excreted, which is a key consideration for patients with renal impairment, according to the National Kidney Foundation 23, 24

Dextromethorphan Dosing Guidelines

Standard Dosing Regimen

The American Thoracic Society recommends a dose of 10-15 mg administered three to four times daily (every 6-8 hours) for effective cough suppression 25
A bedtime dose of 15-30 mg may help suppress cough and promote undisturbed sleep, as suggested by the American College of Chest Physicians 25

Critical Safety Considerations

The American College of Chest Physicians advises exercising caution with combination preparations that contain other ingredients like acetaminophen, as higher doses of dextromethorphan could lead to excessive amounts of these additional ingredients 25
Dextromethorphan has a superior safety profile compared to codeine or pholcodine, with fewer adverse effects including no risk of physical dependence, according to the American College of Chest Physicians 25

Adverse Effects of Promethazine

Safety Profile

Promethazine is associated with serious adverse effects, including hypotension, respiratory depression, neuroleptic malignant syndrome, and extrapyramidal reactions such as restlessness and oculogyric crises, when used for cough suppression or other indications【26】【27】.

Evidence‑Based Recommendations for Antitussive Therapy

Codeine‑Based Antitussives

In adult patients with acute cough, codeine does not provide greater cough‑suppression efficacy than dextromethorphan, indicating no therapeutic advantage over safer alternatives. 28
Codeine is associated with a higher incidence of adverse effects such as drowsiness, nausea, constipation, and risk of physical dependence compared with dextromethorphan. 28
The British Thoracic Society explicitly recommends against the use of codeine‑containing antitussives for cough management. 28

Dextromethorphan as First‑Line Antitussive

Dextromethorphan alone is the recommended first‑line antitussive because it has a superior safety profile relative to codeine‑based products. 28
The optimal dose for maximal cough‑reflex suppression is 30–60 mg per dose (up to 120 mg per day); suppression peaks at 60 mg and can be prolonged at this level. 28

Sedative First‑Generation Antihistamines for Nocturnal Cough

For nighttime cough, first‑generation sedative antihistamines (excluding promethazine) may be used because their sedative properties help reduce cough while promoting sleep. 28

Menthol Inhalation

Inhalation of menthol (e.g., menthol crystals or proprietary capsules) provides acute, short‑lasting cough suppression, useful for temporary symptom relief. 28

Safety Considerations with Dextromethorphan

Caution is required when using higher doses of dextromethorphan, as many combination products also contain acetaminophen, raising the risk of hepatotoxicity. 28

Prescribing Pitfalls to Avoid

Prescribing codeine‑containing products for cough is discouraged because they lack efficacy advantage and increase side‑effect burden. 28
Using sub‑therapeutic doses of dextromethorphan (less than 30 mg) may fail to provide adequate cough relief. 28

Evidence‑Based Pharmacologic Management of Persistent Post‑Infectious Cough

Antitussive Dosing of Dextromethorphan

In adults with persistent dry cough, standard over‑the‑counter doses of dextromethorphan (10–15 mg) are subtherapeutic; maximal cough suppression is achieved with doses of 30–60 mg every 6–8 hours (up to 120 mg/day)【29】.

Minimum Effective Dose Threshold

Dextromethorphan doses below 30 mg are inadequate for meaningful cough suppression in post‑infectious cough【29】.

First‑Generation Sedating Antihistamines for Nocturnal Cough

Administration of a first‑generation sedating antihistamine (e.g., diphenhydramine) at bedtime provides cough‑suppressive effects while promoting sleep in patients with nocturnal cough symptoms【29】.

Menthol Inhalation for Acute Breakthrough Symptoms

Inhalation of menthol (crystals or proprietary capsules) offers short‑lived, acute cough relief for breakthrough episodes in the setting of post‑viral cough【29】.

Comparison with Opioid Antitussives

Codeine and pholcodine do not provide greater cough relief than dextromethorphan but are associated with significantly higher adverse‑effect rates—including drowsiness, nausea, constipation, and risk of physical dependence【29】.

Inefficacy of Expectorant‑Based Syrups in Dry Cough

“Macberry” syrup, which contains typical over‑the‑counter concentrations of dextromethorphan, is likely subtherapeutic for severe dry cough; additionally, expectorants are inappropriate when the cough is non‑productive, as the therapeutic goal is suppression rather than secretion clearance【29】.

Guideline Recommendations for Antitussive Therapy in Acute Dry Cough

Preferred Antitussive According to Major Respiratory Guidelines

The American College of Chest Physicians (ACCP) and the British Thoracic Society (BTS) explicitly recommend dextromethorphan as the preferred antitussive for acute dry cough in otherwise healthy adults, whereas butamirate citrate and levodropropizine are not mentioned in these major guidelines. This recommendation carries strong guideline‑level evidence. 30